Therapy in primary mediastinal B-cell lymphoma [3]

New England Journal of Medicine

Volumn 369, Issue 3, 2013, Pages 282-284

  Woessmann, Wilhelm ^a   Lisfeld, Jasmin ^a   Burkhardt, Birgit ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; RITUXIMAB; VINCRISTINE; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; BLEOMYCIN;

CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CLINICAL PROTOCOL; DRUG EFFICACY; EVENT FREE SURVIVAL; HUMAN; LARGE CELL LYMPHOMA; LETTER; MEDIASTINUM CANCER; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PRIORITY JOURNAL; SURVIVAL RATE; FEMALE; MALE; NOTE; B CELL LYMPHOMA; CANCER RADIOTHERAPY; CARDIOTOXICITY; COMPARATIVE EFFECTIVENESS; DOSE RESPONSE; DRUG DOSE ESCALATION; HODGKIN DISEASE; PRIMARY MEDIASTINAL B CELL LYMPHOMA; PROGRESSION FREE SURVIVAL; SURVIVAL TIME;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE;

EID: 84880400434     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1305983     Document Type: Letter

References (5)

1. Dunleavy K, Pittaluga S, Maeda LS, et al. Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma. N Engl J Med 2013;368:1408-16.
2. Oschlies I, Burkhardt B, Salaverria I, et al. Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children. Haematologica 2011;96:262-8.
3. Seidemann K, Tiemann M, Lauterbach I, et al. Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster Group. J Clin Oncol 2003;21:1782-9. (Pubitemid 46638592)
4. Gerrard M, Waxman IM, Sposto R, et al. Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapy. Blood 2013;121:278-85.
5. Dunleavy K, Pittaluga S, Tay K, et al. Comparative clinical and biological features of primary mediastinal B-cell lymphoma (PMLBL) and mediastinal grey zone lymphoma (MGZL). Blood 2009;114:106. abstract.